NDAORALSYRUPPriority Review
Approved
Sep 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
FLUMADINE (rimantadine hydrochloride) by Forest Devices is mechanism of action the mechanism of action of rimantadine is not fully understood. First approved in 1993.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLUMADINE (rimantadine hydrochloride) is an oral antiviral syrup approved in 1993 for the treatment and prophylaxis of influenza A virus infection. The drug works by inhibiting viral uncoating early in the replicative cycle, likely by targeting the M2 protein specified by the influenza A virion. It is administered orally and represents a small-molecule approach to influenza management.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), the FLUMADINE team is likely in defensive mode, focusing on retained patient populations and managed care retention rather than expansion.
Mechanism of Action
Mechanism of Action The mechanism of action of rimantadine is not fully understood. Rimantadine appears to exert its inhibitory effect early in the viral replicative cycle, possibly inhibiting the uncoating of the virus. Genetic studies suggest that a virus protein specified by the virion M 2 gene…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Joining the FLUMADINE team offers limited growth trajectory but provides experience in managing mature assets, navigating generic competition, and maintaining niche market positions. This role is best suited for professionals seeking stability in established markets or looking to develop defensive commercial strategies rather than launch or expansion experience.
Brand Manager (Specialty/Mature Products)
Worked on FLUMADINE at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.